News
ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine
1. Presentation number: 397P / Poster: ID 680 Title: A phase I cohort expansion trial of OBI-833 in non-small cell lung cancer patients Presenter: Ching-Liang …
OBI Pharma Announces Presentations at ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine
Presentations to highlight the OBI-833 Phase 1 clinical study results in non-small cell lung cancer (NSCLC) and the dose escalation cohort TAIPEI, Taiwan, November 19, …
Company Announcement on Board Resolutions
Please refer to https://www.obipharma.com/2020/09/company-announcement-on-board-resolution/?lang=zh-hant for details.
OBI Pharma Announces OBI-999 Presentation at 2020 World ADC Digital Meeting
Presentation to highlight the scientific characteristics of the novel first-in-class anti Globo H antibody-drug conjugate (ADC), OBI-999. TAIPEI, Taiwan, Sept 14, 2020/PRNewswire/OBI Pharma, Inc. (TPEx: …
Poster Presentations at AACR 2020 Virtual Annual Meeting II
Session PO ET04.02 Identification of molecular targets 2 Title: The role of Globo H in cancer cell survival Presenter: Tzer-Min Kuo, PhD, et. al., OBI …